Global Medical Directory is part of the Informa Markets Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

idnatx capsules 40 mg
Connect with this vendor - Learn about this product

IDNATX 40 MG - Enzalutamide Capsules 40 mg


Medicine composition: Enzalutamide Capsules 40mg

Dosage Form: Tablet

Packing: 4 x 1 x 28 Capsules

Market Authorization: MBA Pharmaceuticals Pvt Ltd

Country Of Origin: India

Similar to Xtandi / Bdenza


(Enzalutamide Capsules 40 mg) For the treatment of adults with metastatic castration-resistant prostate cancer (mCRPC) whose disease has progressed on or after Docetaxel therapy.